Auxly Cannabis Group (OTCPK:CBWTF) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Auxly Cannabis Group EBITDA Margin % Related Terms
Auxly Cannabis Group EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Auxly Cannabis Group's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Auxly Cannabis Group's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Auxly Cannabis Group EBITDA Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Auxly Cannabis Group's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Auxly Cannabis Group's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Auxly Cannabis Group (CBWTF) has a EBITDA Margin % of 18.98% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Auxly Cannabis Group and its competitors. According to the industry distribution chart, Auxly Cannabis Group ranks #118 out of 953 companies in the Drug Manufacturers industry, placing it in the top 12.4%.
Is Auxly Cannabis Group's EBITDA Margin % too high?
Auxly Cannabis Group's current EBITDA Margin % is 18.98%. The Drug Manufacturers industry median EBITDA Margin % is 12.49. Auxly Cannabis Group's value of 18.98% is 52% above this industry median. Based on the distribution chart, Auxly Cannabis Group ranks #118 out of 953 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Auxly Cannabis Group has a GF Score™ of 36/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Auxly Cannabis Group's EBITDA Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Auxly Cannabis Group ranks #118 out of 953 companies for EBITDA Margin %. This places Auxly Cannabis Group in the top 12% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 12.49. Auxly Cannabis Group's value of 18.98% is 52% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Drug Manufacturers company?
The median EBITDA Margin % among Drug Manufacturers companies is 12.49, based on 953 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Auxly Cannabis Group's current EBITDA Margin % of 18.98% is 52% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Auxly Cannabis Group and its competitors. For the Drug Manufacturers industry, the median EBITDA Margin % is 12.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Auxly Cannabis Group's current EBITDA Margin % is 18.98%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Auxly Cannabis Group stock overvalued right now?
Based on GuruFocus' analysis, Auxly Cannabis Group (CBWTF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.03, compared to a current price of $0.12 — trading 308% above its estimated fair value. The current EBITDA Margin % is 18.98% and 52% above the Drug Manufacturers industry median of 12.49. Auxly Cannabis Group's overall GF Score™ is 36/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Auxly Cannabis Group (CBWTF), the current EBITDA Margin % is 18.98% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Auxly Cannabis Group (CBWTF) Overvalued in 2026?
Based on GuruFocus' analysis, Auxly Cannabis Group stock appears to be overvalued.
The current stock price of $0.12 is trading 308% above its estimated GF Value™ of $0.03.
GuruFocus considers Auxly Cannabis Group to be Significantly Overvalued.
Key valuation signals for CBWTF:
EBITDA Margin %: 18.98%
GF Value™: $0.03 vs. price of $0.12 (308% above fair value)
Industry Position: 52% above the Drug Manufacturers median (#118 of 953)
No single metric tells the full story. See the CBWTF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Auxly Cannabis Group Inc is a consumer-packaged-goods company in the cannabis products market. The company has created a portfolio of brands designed for a broad market of cannabis consumers, with differentiation in price points across targeted consumer segments. Its product portfolio comprises dried cannabis, fresh cannabis, cannabis plants, cannabis seeds, cannabis oil, edible cannabis, cannabis extracts, and cannabis topicals, among others, which are marketed through brands like Parcel, Black Forty, Foray, Dosecann, and Kolab Project.
36GF Score
Get the complete analysis for CBWTF
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CBWTF has been successfully added to your 
